Proactive

Royal Helium Ltd.(TSX-V:RHC, OTCQB:RHCCF) told investors it continues to ramp up operations at its Steveville #helium production facility located near Brooks, Alberta. The helium-focused production, infrastructure and exploration firm reported that it has now shipped both the 10th and 11th purified helium trailers from the facility. More at #Proactive #ProactiveInvestors http://ow.ly/SQji105v5rS

Copper Lake Resources Ltd CEO Terry MacDonald joined Steve Darling from Proactive to share the results generated from the recently completed winter diamond drilling program on its Marshall Lake #copper-#zinc-#silver VMS property in Northwestern Ontario. The company focused its drilling efforts on two new target areas, including a prominent magnetotelluric conductor situated proximal to and below high-grade copper-zinc-silver mineralization known as the Conductive Centre. Watch at #Proactive #ProactiveInvestors http://ow.ly/LXVs105v5O0

TNR Gold Corp. (TSX-V:TNR, OTC:TRRXF) could see royalty payments from Ganfeng Lithium’s Mariana #Lithium Project in Argentina as soon as 2025, which is set to boost the stock significantly, analysts at Fundamental Research believe. They awarded TNR Gold a ‘fair value’ target of C$0.24, representing an upside of almost 250% from its current share price of C$0.07. More at #Proactive #ProactiveInvestors http://ow.ly/qCpg105v5U3

Replenish Nutrients Holding Corp (CSE:ERTH, OTC:VVIVF) reported a year-over-year increase in revenue and sales volumes to third-party customers for the first quarter, which it said demonstrated consistent and growing demand for its fertilizer products. The agricultural bioscience company, which is developing regenerative and sustainable fertilizer solutions, said that during the quarter its granulated fertilizer product being produced at its Beiseker facility in Alberta demonstrated strong pricing and margins compared to the blended product. More at #Proactive #ProactiveInvestors http://ow.ly/gS2Q105v5Ql

BiVictriX Therapeutics plc's (AIM:BVX, OTC:BVTXF) boss said 2023 had been a remarkable year for the cancer drug developer, especially BVX001, its lead treatment for Acute Myeloid Leukaemia. Tiffany Thorn, chief executive, said: "We have made considerable progress with BVX001, the company's lead bispecific ADC [targeted cancer drug], towards getting this asset ready for the clinic, identifying our route to market and attracting the support of globally recognised KOLs [opinion leaders] in the AML space. More at #Proactive #ProactiveInvestors http://ow.ly/hAc9105v5Qk

Forward Water Technologies Corp (TSX-V:FWTC) told investors it is actively pursuing opportunities to develop direct #lithium extraction (DLE) projects. The company, in a statement, has given a commercial update following enquiries received since its previous update, on March 20. More at #Proactive #ProactiveInvestors http://ow.ly/cL1z105v5U1

Tribe Property Technologies Inc. (TSX-V:TRBE) has unveiled impressive quarterly results marked by record revenue and an improvement in profitability, which sent shares of the tech-driven #property management firm 25% higher before Friday's opening bell.  For the first quarter ended March 31, Tribe achieved revenue of C$5.3 million, up 14.6% from C$4.7 million in the year-ago quarter. More at #Proactive #ProactiveInvestors http://ow.ly/8sRi105v5WM

Quadrise Plc (AIM:QED) shot to the top of the small-cap movers list after the alternative fuel developer added another top name to its rapidly expanding roster of clients. Morocco-based fertiliser and phosphate giant OCP is the latest to announce a trial, following the announcement in April of a binding agreement between Quadrise, shipping company MSC and Cargill, the crops and food transportation business. More at #Proactive #ProactiveInvestors http://ow.ly/Hnf2105v5r0

Rakovina Therapeutics Inc (TSX-V:RKV) made a strategic shift to include AI in its drug development efforts during the first quarter of 2024, announcing that it has been granted exclusive access to the proprietary Deep Docking AI Platform for DNA damage response targets. This platform allows the biopharmaceutical firm, which is advancing new cancer therapies based on novel DNA-damage response technologies, to analyze billions of molecular structures to evaluate their potential as targeted cancer drugs. More at #Proactive #ProactiveInvestors http://ow.ly/AlhW105v5WN

Plurilock Inc. (TSX-V:PLUR) has highlighted its growth in key business areas as it released a positive set of quarterly financial results. The identity-centric cybersecurity specialist reported a significant increase in gross margin, which reached $2.5 million, or 21.9% of sales, compared to $2.1 million, or 13.6%, in the first quarter of 2023. More at #Proactive #ProactiveInvestors http://ow.ly/cY7Y105v5WO